{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:40:56Z","timestamp":1791196856306,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T00:00:00Z","timestamp":1389916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00253-013-5425-5","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T06:29:38Z","timestamp":1389853778000},"page":"2609-2616","source":"Crossref","is-referenced-by-count":32,"title":["ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility"],"prefix":"10.1007","volume":"98","author":[{"given":"Biao","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Qin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Jun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Zhuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,17]]},"reference":[{"key":"5425_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18388\/abp.2005_3426","volume":"52","author":"M Baginski","year":"2005","unstructured":"Baginski M, Sternal K, Czub J, Borowski E (2005) Molecular modelling of membrane activity of amphotericin B, a polyene macrolide antifungal antibiotic. Acta Biochim Pol 52:1\u20134","journal-title":"Acta Biochim Pol"},{"key":"5425_CR2","doi-asserted-by":"crossref","unstructured":"Ben-Yaacov R, Knoller S, Caldwell GA, Becker JM, Koltin Y (1994) Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother 38(4):648\u2013652","DOI":"10.1128\/AAC.38.4.648"},{"key":"5425_CR3","doi-asserted-by":"crossref","unstructured":"Bossche HV, Willemsens G, Marichal P (1987) Anti-Candida drugs\u2014the biochemical basis for their activity. Crit Rev Microbiol 15(1):57\u201372","DOI":"10.3109\/10408418709104448"},{"issue":"4","key":"5425_CR4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/CMR.9.4.512","volume":"9","author":"J Brajtburg","year":"1996","unstructured":"Brajtburg J, Bolard J (1996) Carrier effects on biological activity of amphotericin B. Clin Microbiol Rev 9(4):512\u2013531","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"5425_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/AAC.34.2.183","volume":"34","author":"J Brajtburg","year":"1990","unstructured":"Brajtburg J, Powderly WG, Kobayashi GS, Medoff G (1990) Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother 34(2):183\u2013188","journal-title":"Antimicrob Agents Chemother"},{"key":"5425_CR6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/jf60075a005","volume":"5","author":"ON Breivik","year":"1957","unstructured":"Breivik ON, Owades JL (1957) Spectrophotometric semimicrodetermination of ergosterol in yeast. J Agric Food Chem 5:360\u2013363","journal-title":"J Agric Food Chem"},{"issue":"20","key":"5425_CR7","doi-asserted-by":"crossref","first-page":"12612","DOI":"10.1074\/jbc.273.20.12612","volume":"273","author":"A Decottignies","year":"1998","unstructured":"Decottignies A, Grant AM, Nichols JW, de Wet H, McIntosh DB, Goffeau A (1998) ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J Biol Chem 273(20):12612\u201312622","journal-title":"J Biol Chem"},{"key":"5425_CR8","doi-asserted-by":"crossref","unstructured":"Dogra S, Krishnamurthy S, Gupta V, Dixit BL, Gupta CM, Sanglard D, Prasad R (1999) Asymmetric distribution of phosphatidylethanolamine in C. albicans: possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily. Yeast 15:111\u2013121","DOI":"10.1002\/(SICI)1097-0061(19990130)15:2<111::AID-YEA350>3.0.CO;2-E"},{"key":"5425_CR9","unstructured":"Fonzi WA, Irwin MY (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134(3):717\u2013728"},{"key":"5425_CR10","doi-asserted-by":"crossref","unstructured":"Gallagher PJ, Bennett DE, Henman MC, Russell RJ, Flint SR, Shanley DB, Coleman DC (1992) Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation. J Gen Microbiol 138(9):1901\u20131911","DOI":"10.1099\/00221287-138-9-1901"},{"key":"5425_CR11","doi-asserted-by":"crossref","unstructured":"Gillum A, Tsay EH, Kirsch D (1984) Isolation of the Candida albicans gene for orotidine-5rsch D (1984) Isolation of the ing colony mo of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198(1):179\u2013182. doi: 10.1007\/bf00328721","DOI":"10.1007\/BF00328721"},{"issue":"7187","key":"5425_CR12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/452541a","volume":"452","author":"A Goffeau","year":"2008","unstructured":"Goffeau A (2008) Drug resistance: the fight against fungi. Nature 452(7187):541\u2013542","journal-title":"Nature"},{"issue":"6","key":"5425_CR13","doi-asserted-by":"crossref","first-page":"e11309","DOI":"10.1371\/journal.pone.0011309","volume":"5","author":"W Guan","year":"2010","unstructured":"Guan W, Jiang H, Guo X, Mancera E, Xu L, Li Y, Steinmetz L, Li Y, Gu Z (2010) Antagonistic changes in sensitivity to antifungal drugs by mutations of an important ABC transporter gene in a fungal pathogen. PLoS ONE 5(6):e11309","journal-title":"PLoS ONE"},{"issue":"3","key":"5425_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.4.3.309","volume":"4","author":"C-C Hsuchen","year":"1973","unstructured":"Hsuchen C-C, Feingold DS (1973) Selective membrane toxicity of the polyene antibiotics: studies on lecithin membrane models (liposomes). Antimicrob Agents Chemother 4(3):309\u2013315","journal-title":"Antimicrob Agents Chemother"},{"key":"5425_CR15","doi-asserted-by":"crossref","unstructured":"Karababa M, Coste AT, Rognon B, Bille J, Sanglard D (2004) Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother 48(8):3064\u20133079","DOI":"10.1128\/AAC.48.8.3064-3079.2004"},{"key":"5425_CR16","doi-asserted-by":"crossref","unstructured":"Lamping E, Monk BC, Niimi K, Holmes AR, Tsao S, Tanabe K, Niimi M, Uehara Y, Cannon RD (2007) Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot Cell 6(7):1150\u20131165","DOI":"10.1128\/EC.00091-07"},{"key":"5425_CR17","doi-asserted-by":"crossref","unstructured":"Larsen RA, Bauer M, Thomas AM, Graybill JR (2004) Amphotericin B and fluconazole, a potent combination therapy for Cryptococcal Meningitis. Antimicrob Agents Chemother 48(3):985\u2013991","DOI":"10.1128\/AAC.48.3.985-991.2004"},{"key":"5425_CR18","doi-asserted-by":"crossref","unstructured":"Lewis RE, Lund BC, Klepser ME, Ernst EJ, Pfaller MA (1998) Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model. Antimicrob Agents Chemother 42(6):1382\u20131386","DOI":"10.1128\/AAC.42.6.1382"},{"issue":"10","key":"5425_CR19","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1128\/AAC.46.10.3208-3214.2002","volume":"46","author":"RE Lewis","year":"2002","unstructured":"Lewis RE, Prince RA, Chi J, Kontoyiannis DP (2002) Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis. Antimicrob Agents Chemother 46(10):3208\u20133214","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5425_CR20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1128\/AAC.38.6.1331","volume":"38","author":"E Martin","year":"1994","unstructured":"Martin E, Maier F, Bhakdi S (1994) Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum. Antimicrob Agents Chemother 38(6):1331\u20131338","journal-title":"Antimicrob Agents Chemother"},{"key":"5425_CR21","doi-asserted-by":"crossref","unstructured":"Micheli MD, Bille J, Schueller C, Sanglard D (2002) A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance. Mol Microbiol 43(5):1197\u20131214. doi: 10.1046\/j.1365-2958.2002.02814.x","DOI":"10.1046\/j.1365-2958.2002.02814.x"},{"issue":"12","key":"5425_CR22","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1128\/AAC.46.12.3695-3705.2002","volume":"46","author":"K Mukhopadhyay","year":"2002","unstructured":"Mukhopadhyay K, Kohli A, Prasad R (2002) Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob Agents Chemother 46(12):3695\u20133705","journal-title":"Antimicrob Agents Chemother"},{"key":"5425_CR23","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay K, Prasad T, Saini P, Pucadyil TJ, Chattopadhyay A, Prasad R (2004) Membrane sphingolipid\u2013ergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrob Agents Chemother 48(5):1778\u20131787","DOI":"10.1128\/AAC.48.5.1778-1787.2004"},{"key":"5425_CR24","unstructured":"National Committee for Clinical Laboratory Standards (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts approved standard, 2nd edn M27-A2. Approved Standard-2nd edn, Pennsylvania, USA"},{"key":"5425_CR25","doi-asserted-by":"crossref","unstructured":"Pasrija R, Prasad T, Prasad R (2005) Membrane raft lipid constituents affect drug susceptibilities of Candida albicans. Biochem Soc Trans 33:1219\u20131223","DOI":"10.1042\/BST20051219"},{"key":"5425_CR26","doi-asserted-by":"crossref","unstructured":"Pasrija R, Panwar SL, Prasad R (2008) Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts. Antimicrob Agents Chemother 52(2):694\u2013704","DOI":"10.1128\/AAC.00861-07"},{"issue":"1","key":"5425_CR27","first-page":"62","volume":"86","author":"R Prasad","year":"2004","unstructured":"Prasad R, Panwar S (2004) Physiological functions of multidrug transporters in yeast. Curr Sci 86(1):62\u201373","journal-title":"Curr Sci"},{"key":"5425_CR28","doi-asserted-by":"crossref","unstructured":"Prasad R, Wergifosse DP, Goffeau A, Balzi E (1995) Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27(4):320\u2013329","DOI":"10.1007\/BF00352101"},{"key":"5425_CR29","doi-asserted-by":"crossref","unstructured":"Redding S, Smith J, Farinacci G, Rinaldi M, Fothergill A, Rhine-Chalberg J, Pfaller M (1994) Resistance of Candida albicans to fluconazole during treatment of oropharyngeal Candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 18(2):240\u2013242","DOI":"10.1093\/clinids\/18.2.240"},{"key":"5425_CR30","doi-asserted-by":"crossref","unstructured":"Rodriguez MM, Serena C, Marine M, Pastor FJ, Guarro J (2008) Posaconazole combined with amphotericin B, an effective therapy for a murine-disseminated infection caused by Rhizopus oryzae. Antimicrob Agents Chemother 52:3786\u20133788","DOI":"10.1128\/AAC.00628-08"},{"key":"5425_CR31","doi-asserted-by":"crossref","unstructured":"Sanglard D, Ischer F, Monod M, Bille J (1996) Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40(10):2300\u20132305","DOI":"10.1128\/AAC.40.10.2300"},{"key":"5425_CR32","doi-asserted-by":"crossref","unstructured":"Sanglard D, Ischer F, Monod M, Bille J (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143(2):405\u2013416","DOI":"10.1099\/00221287-143-2-405"},{"key":"5425_CR33","doi-asserted-by":"crossref","unstructured":"Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J (2003) Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 47(8):2404\u20132412. doi: 10.1128\/aac.47.8.2404-2412.2003","DOI":"10.1128\/AAC.47.8.2404-2412.2003"},{"issue":"5","key":"5425_CR34","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/infdis\/151.5.902","volume":"151","author":"A Schaffner","year":"1985","unstructured":"Schaffner A, Frick PG (1985) The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. J Infect Dis 151(5):902\u2013910","journal-title":"J Infect Dis"},{"issue":"257\u2013269","key":"5425_CR35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01871064","volume":"79","author":"SG Schultz","year":"1984","unstructured":"Schultz SG, Thompson SM, Hudson R, Thomas SR, Suzuki Y (1984) Electrophysiology of Necturus urinary bladder: II. Time-dependent current\u2013voltage relations of the basolateral membranes. J Membrane Biol 79(257\u2013269):257","journal-title":"J Membrane Biol"},{"key":"5425_CR36","doi-asserted-by":"crossref","unstructured":"White TC (1997) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41(7):1482\u20131487","DOI":"10.1128\/AAC.41.7.1482"},{"issue":"2","key":"5425_CR37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","volume":"11","author":"TC White","year":"1998","unstructured":"White TC, Marr KA, Bowden RA (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11(2):382\u2013402","journal-title":"Clin Microbiol Rev"},{"key":"5425_CR38","doi-asserted-by":"crossref","unstructured":"Xu Z, Zhang LX, Zhang JD, Cao YB, Yu YY, Wang DJ, Ying K, Chen WS, Jiang YY (2006) cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients. Int J Med Microbiol 296(6):421\u2013434","DOI":"10.1016\/j.ijmm.2006.03.004"},{"issue":"11","key":"5425_CR39","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1073\/pnas.0609370104","volume":"104","author":"L Zhang","year":"2007","unstructured":"Zhang L, Yan K, Zhang Y, Huang R, Bian J, Zheng C, Sun H, Chen Z, Sun N, An R, Min F, Zhao W, Zhuo Y, You J, Song Y, Yu Z, Liu Z, Yang K, Gao H, Dai H, Zhang X, Wang J, Fu C, Pei G, Liu J, Zhang S, Goodfellow M, Jiang Y, Kuai J, Zhou G, Chen X (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc Natl Acad Sci U S A 104(11):4606\u20134611","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-013-5425-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00253-013-5425-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-013-5425-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T06:16:00Z","timestamp":1597385760000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-013-5425-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,17]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["5425"],"URL":"https:\/\/doi.org\/10.1007\/s00253-013-5425-5","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,17]]}}}